Elsevier

The Lancet

Volume 326, Issue 8459, 12 October 1985, Pages 829-830
The Lancet

Letters to the Editor
MENINGOCOCCAL DISEASE AND SEASON IN SUB-SAHARAN AFRICA

https://doi.org/10.1016/S0140-6736(85)90812-8Get rights and content

References (3)

There are more references available in the full text version of this article.

Cited by (59)

  • Neisseria meningitidis

    2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  • Fever and Systemic Symptoms. Mechanisms and Examples

    2011, Tropical Infectious Diseases: Principles, Pathogens and Practice
  • Fever and Systemic Symptoms

    2011, Tropical Infectious Diseases
  • Neisseria meningitidis

    2009, Vaccines for Biodefense and Emerging and Neglected Diseases
  • MENINGOCOCCAL INFECTIONS

    2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition
  • Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: Implications for introducing PorA based vaccines

    2008, Vaccine
    Citation Excerpt :

    Despite the high population density the yearly overall meningococcal endemic incidence rate is 3.2–5.1 per 100,000 population, similar to the incidence rates reported in other European countries, such as the UK and Ireland [24]. By contrast incidence rates of meningococcal disease in countries in the ‘meningitis belt’ of sub-Saharan Africa reach 10–25 cases per 100,000 population per year [25] and escalate to 1000 cases per 100,000 population during epidemics [26]. The mean case fatality ratio (CFR) of 8.6% (1999–2005) in Malta, where the majority of invasive meningococcal disease (IMD) cases are caused by MenB, is similar to the overall CFR in Europe [24,27].

View all citing articles on Scopus
View full text